Actively Recruiting
Dose Efficacy in Adhesive Capsulitis
Led by University Health Network, Toronto · Updated on 2025-02-27
40
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to find out if the treatment of adhesive capsulitis with 40 mg of methylprednisolone in combination with a hydrodilatation is comparable to 80 mg of methylprednisolone for pain reduction, improving shoulder mobility, and reducing side effects. Researchers will enroll 40 people in this study which is taking place solely at the Toronto Rehabilitation Institute, University Avenue. This study should take approximately 12 months to complete and the results should be known in about 15 to 18 months. During this study, patients will receive an ultrasound guided shoulder hydrodilatation combined with corticosteroid after "randomized" into one of the groups (40 mg vs 80 mg). This is a double blind study as both patients and physicians would not know the group patient was randomized to. Pain scores, Range of Motion and few other questionnaires wold be completed to track the response to the interventions at baseline prior to injection, four weeks after the procedure and 3 months after the procedure.
CONDITIONS
Official Title
Dose Efficacy in Adhesive Capsulitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age
- Diagnosed with adhesive capsulitis of the shoulder
You will not qualify if you...
- Injection received in the affected shoulder within the last 3 months (any kind)
- History of previous surgery in the affected shoulder
- Glenohumeral osteoarthritis more than mild on x-ray
- Pregnancy
- Use of blood thinners other than Aspirin 80 mg or bleeding disorder
- Active infection requiring antibiotics
- Allergy to steroid or lidocaine
- Cognitive impairment
- Active litigation
- Inflammatory connective tissue disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toronto Rehabilitation Institution
Toronto, Ontario, Canada, M9C 2X8
Actively Recruiting
Research Team
N
Nimish Mittal
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here